Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Palm Tocotrienol Rich Fraction on Alcoholic Fatty Liver Disease (AFLD): A Phase II Clinical Trial

NCT07466485 is registered in ClinicalTrials.gov with Universiti Kebangsaan Malaysia Medical Centre as lead sponsor.

NCT NCT07466485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07466485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Palm Tocotrienol Rich Fraction on Alcoholic Fatty Liver Disease (AFLD): A Phase II Clinical Trial
Lead sponsor
Universiti Kebangsaan Malaysia Medical Centre
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 2, 2026
Completion date
February 15, 2027
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic fatty liver disease